JeNaCell Receives Seed Financing from High-Tech Gründerfonds and STIFT
High-Tech Gründerfonds and STIFT are jointly investing €700,000 in JeNaCell GmbH
Dr. Heßler, Dr. Kralisch, and their team have succeeded in developing an efficient production process through which the fascinating biomaterial can be offered on the market in large quantities, at high quality, and economically. The seed capital is to be used for optimizing the products as well as building up an automated production facility. In addition, the financing will fund preparatory measures for the market introduction of the high-tech biomaterial.
“We are very happy that we have received the financial support from High-Tech Gründerfonds and STIFT that we need to grow from developmental work to an industrial scale,” says Dr. Nadine Hessler, CEO of JeNaCell GmbH.
Most read news
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.